Τεύχος 15

15
ΦΘΙΝΟΠ
ΩΡ
Ο 2011
Η Φροντίδα του
Nεογέννητου
Μητρικός Θηλασμός
Υπέρταση & Κύηση
Σιδηροπενική
Aναιμία
Προεμφυτευτικός
Προγεννητικός Έλεγχος
Παιδική Παχυσαρκία
& ∆ιατροφή
ΑΥΞΗΤΙΚΗ ΜΑΣΤΩΝ ΤΕΧΝΟΛΟΓΙΑ & ΑΠΟΚΑΤΑΣΤΑΣΗ
ΣΑΚΧΑΡΩ∆ΗΣ ∆ΙΑΒΗΤΗΣ & ΗΠΑΡ ΛΑΒΥΡΙΝΘIΚΕΣ ΠΑΘΗΣΕΙΣ - ΙΛΙΓΓΟΣ
ΑΞΟΝΙΚΗ ΚΟΛΟΝΟΓΡΑΦΙΑ ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΡΟΣΤΑΤΗ & ∆ΙΑΤΡΟΦΗ

editorial
Editorial
editorial
,
-
.
,
My Life Magazine -
.
,
, .
,
&
,
.
-
My Club Card VISA -
. -
www.myclubcard.gr
!
.
..
MYLIFE 1

15
ΦΘΙΝΟΠ
ΩΡ
Ο 2011
- 04 -
N
- 08 -
- 12 -
&
- 18 -
- 24 -
&
- 28 -
'
- 34 -
&
- 38 -
- .
- 42 -
- 44 -
&
- 46 -
- 48 -
&
- 52 -
- 59 -
My Club Card Visa
- 62 -
- 64 -
Η Φροντίδα του
Nεογέννητου
Μητρικός Θηλασμός
Υπέρταση & Κύηση
Σιδηροπενική
Aναιμία
Προεμφυτευτικός
Προγεννητικός Έλεγχος
Παιδική Παχυσαρκία
& ∆ιατροφή
ΑΥΞΗΤΙΚΗ ΜΑΣΤΩΝ ΤΕΧΝΟΛΟΓΙΑ & ΑΠΟΚΑΤΑΣΤΑΣΗ
ΣΑΚΧΑΡΩ∆ΗΣ ∆ΙΑΒΗΤΗΣ & ΗΠΑΡ ΛΑΒΥΡΙΝΘΗΚΕΣ ΠΑΘΗΣΕΙΣ - ΙΛΙΓΓΟΣ
MedStem Services
. 37-39,
: 210 6184000
Fax: 210 6184158
www.iaso.gr
&
:15 2011
-
I 10design.gr
2 MYLIFE

MYLIFE 3

N
•
.
• - .
, .
• .
.
.
4 MYLIFE

.
-
. -
.
.
.
. , , ,
, .
(-
37 0 C)
.
25 0 C.
-
. .
, ,
.
,
. -
-
. ,
.
,
.
. .
.
•
– .
.
•
’
.
• , , ,
, .
• (1) ,
,
.
MYLIFE 5

, . ,
-
.
, ,
, -
.
-
, -
.
.
.
, ,
. .
.
,
.
. -
. -
. ,
. ,
.
, -
.
.
, ,
.
, ,
.
6 MYLIFE

-
6
. -
,
12 ,
,
, -
.
,
-
.
, -
-
.
,
-
.
-
,
,
8 MYLIFE

,
.
.
-
,
,
.
,
,
-
.
-
.
2 - 3
(, , -
).
,
.
.
, -
.
-
.
.
MYLIFE 9

,
,
.
-
24
.
:
•
•
•
•
•
•
•
•
•
, ,
-
•
•
,
,
,
.
, -
,
.
, -
,
,
.
,
-
-
.
,
.
1. Characterization of Focal Liver Lesions by Means of Assessment of Hepatic Transit Time with Contrast- enhanced US Zhou X, Liu JB, Luo Y, Yan F, Peng
Y, Lin L, Zhuang H. Radiology. 2010 Aug; 256(2):648-55. 2. Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Focal Liver Lesions in
Clinical Practice (DEGUM Multicenter Trial: CEUS vs. MRI –a Prospective Compariosn in 269 Patients Seitz K, Bernatik T, Strobel D, Blank W, Friedrich-Rust
M, Strunk H, Greis C, Kratzer W, Schuler A. Ultraschall Med. 2010 Jul 22.
10 MYLIFE

ΤΟ ΜΠΙΜΠΕΡΟΝ ΠΟΥ ΑΛΛΑΖΕΙ ΤΟΝ ΤΡΟΠΟ ΠΟΥ ΤΑΪΖΟΥΜΕ ΤΟ ΜΩΡΟ.
6 m+
0 m+ Η μόνη θηλή με κλίση: πάντα γεμάτη
γάλα, μειώνει τις πιθανότητες κολικών.
Από την πρώτη μέρα.
2 m+
4 m+
Η λιγότερο στρογγυλεμένη βάση και η
μακριά ελαστική θηλή διευκολύνουν
το φυσικό «πιπίλισμα». Από τον έκτο
μήνα.
Η μαλακή, πολύ φαρδιά,
καμπυλωτή βάση έχει ανάγλυφες
ραβδώσεις στην θηλή για να μοιάζει
όσο γίνεται περισσότερο στο μητρικό
στήθος.
Από το δεύτερο μήνα.
Το Step Up είναι το μπιμπερόν που ακολουθεί
την ανάπτυξη του μωρού και εξελίσσεται μαζί
του. Οι τρεις θηλές του είναι σχεδιασμένες για να
προσαρμόζονται στην ανάπτυξη του στόματος,
που αλλάζει μήνα με το μήνα και ακολουθούν την
εξέλιξη στον τρόπο που “πιπιλίζει” το μωρό καθώς
μεγαλώνει. Γιατί τα μωρά μεγαλώνουν βήμα βήμα
και τώρα το Step Up βρίκεται δίπλα τους.
Δείτε το νέο site: www.chicco.gr,
www.stepup.chicco.com
MYLIFE 11

-
,
. -
8-10%
.
.
M - .
10-15mmHg
.
.
H :
• >=140/90mmHg
•
>25mmHg >15mmHg
1 .
-
-
.
. -
( 1% )
>140/90mmHg
12 MYLIFE

H
,
.
20
. -
. -
.
( 5-6% ) -
20 -
. -
.
( 1-2% )
(>300 mg/24)
20
30.
:
1. 2. .
. 5%
, 10% 20-
25% . 10%
.
HELLP, -
(haemolysis) (elevated liver
enzymes) (low platelet count).
25 36
. 20%
. 6
10-12 .
-
,
.
-
-
. ,
-
-
.
.
-
-
, , , ,
. -
,
,
.
.
H , -
. , -
, ,
,
.
.
-
.
-
.
.
,
,
,
.
MYLIFE 13

.
. -
(+), -
.
,
.
,
, .
>160 >110 mmHg
-
.
• 1
• 35
•
•
• 10
•
•
•
•
.
6.
:
1. .
2.
.
• ,
, .
• , , , ,
, .
•
: (+)
. (++)
24 spot
/ .
3.
: ,
, , ,
.
4.
:
Doppler, NST (-
), .
14 MYLIFE

MYLIFE 15

. -
10 .
( )/ -
-
4 - 6 mm .
DASH 5 ( ,
-
,
, -
) -
-
.
.
.
. -
>115mmHg
, -
>165mmHg -
.
160
100-105mmHg . -
.
-
>160 /
>90mmHg.
- -
-
-
2 3 .
-
.
, lampetalol ’
90
mmhg.
-
-
. -
.
!
,
2-3 24 , -
,
, 26 28
. 7
1. .., () 2. www.nefrologia.gr / 3. www.healthierworld.gr 4. .gr/
-image7.16-01-2011 5. www.rotise.gr/anazitisi-erotiseon 6-7. www.enet.gr 11-03-2008 ( )
16 MYLIFE

MYLIFE 17

&
.
-
’ -
DNA.
, -
2 .. -
«» ,
17 Sydenham -
-
.
,
65% -
-
. -
-
.
, -
, -
. -
,
.
5
-
-
.
-
18 MYLIFE

&
-
-
.
-
(.. - )
.
-
. -
. -
-
.
-
. ’
-
.
.
.
-
.
. -
()
( ).
.
;
.
.
-
.
MYLIFE 19

,
.
-
, 2
, . -
-
2-3% 15-30%
(
). -
0-2
16% 34% ,
,
.
, -
.
, -
-
.
-
. -
, , ,
, -
, -
, ,
.
-
-
.
. -
, -
.
.
,
,
, .
, -
.
• ( – )
• ( – )
• ( ,
, C, -).
•
•
•
•
•
•
;
&
• ,
.
•
6 .
• , 1 .
• 700ml .
• .
• .
• -
20 MYLIFE

,
.
1-2 . ( -
) 6 9
( 5
). -
,
.
(
).
-
, -
-
18
.
-
(
, , ,
..) C ( -
).
(, ).
. ,
(50-100mg ). -
-
,
2-3 .
, -
,
. -
.
&
1. Capozzzi L, Russo R, Bertocco F, Ferrara D, and Ferrara M. Diet and iron deficiency in the first year of life: a retrospective study. Hematology,
2010 15(6):410-413. 2. Ferrara M, Coppola L, Coppola A, Capozzi L. "Iron deficiency in children and adolescence: Retrospective review", Hematology,
2006 11(3):183-186. 3. Lin JD, Lin PY, Lin LP, Hsu SW, Loh CH, Yen CF, Fang WH, Chien WC, Tang CC, Wu CL. Prevalence and associated risk factors of
anemia in children and adolescents with intellectual disabilities. Res Dev Disabil 2010, 31(1):25-32. 4. Male C. Persson LA, Freeman V, Guerra A, van't
Hof MA, Haschke F; Euro-Growth Iron Study Group. Prevalence of iron deficiency in 12-mo-old infants from 11 European areas and influence of
dietary factors on iron status (Euro-Group Study) Acta Pediatrica; 2001 90(5):492-498. 5. Wick M, Pinggera W, Lehmen P. Iron metabolism, Anemias
Diagnosis and Therapy, 4th ed, Springer-Verlag, Wien, 2000. 6. , , - .
. , 1998, 61(4):375-380. 7. , , - . :
- . ,1999, 62:24-30. 8. , - , , , .
. . 37
, 1999, 650.
22 MYLIFE

Ασφαλώς η καλύτερη επιλογή
για το παιδί ! ! !
Alondra Compo
Cordoba
Kidscom sa 200 .
optima
«»
!
‘
.
’
.
kidscom
.
.
design ,
.
, kidscom
!
Leander
Recaro Acuna travel set
Maclaren travel set
Recaro young sport
Recaro Babyzen travel set
4. : . 3, .2106014624
4: . 62 , . 2109830570
4: . 128, . 2108067150
4, : . 9, .00357 22 676 777
4e-shop: www.kidscom.gr http://www.kidscom.gr MYLIFE 23

&
-
/
-
-
,
(), -
( , , -
, ) -
2. -
,
.
,
. , -
-
-
.
, -
/
,
.
()
()
HDL -
-
.
/
, -
, -
.
.
,
24 MYLIFE

&
.
:
1. , (, , ),
2. (, ),
3. /,
.
,
/ , -
- ,
, -
.
, 29 , (10-14
), () 85 -
.
,
« » -
, «-
.
. 15
( Sweet & Balance) -
3 , , (-500kcal
)
( 45%, 35%,
20%), -
Sweet & Balance, 4 /.
14 ( )
3 , -
,
,
,
-
1 /.
MYLIFE 25

.
,
-
(,
, HDL, LDL, , SGOT, SGPT,
Gt, , , , ,
, hsCRP, 6).
HOMA index -
.
SPSS 16.0.
p-value < 0,05.
Mann Whitney
Wilcoxon.
/, -
-
, -
.
.
-
. -
/
-
.
&
/ -
,
,
: i) , ii)
(BMI), iii) -
, iv) , v) HOMA
Index, vi) .
-
() 93 -
(4-7 2011), Dr. , .
: . , . , . , . -Gantenbein, ..
: « »
26 MYLIFE

A KA
www.sweetandbalance.gr
MYLIFE 27

ARRAY CGH
.
-
.
-
(IVF)
-
-
-
,
.
. -
-
IVF -
. , -
-
IVF.
(Caglar et al., 2005; Gianaroli et al., 2005; Donoso
and Devroey, 2007; Kuliev & Verlinsky, 2008; Munne
et al., 2003, 2007a,b).
"-
" in situ
(FISH) 5-7
(.. 13, 16, 18, 21, 22, ),
.
-
. -
(
)
.
( ) -
( ).
- , , .
, ‘Intergenetics’
28 MYLIFE

.
( 2-3 ) -
,
. -
(3 )
40-50%
-
() -
-
() (Voullaire et al., 2000; Wells
and Delhanty, 2000).
(5 -6 )
-
,
3
(Frqagouli et al., 2011).
ARRAY CGH
, ARRAY CGH -
-
. -
(Fishel et al., 2010; Gutierez-Mateo et al., 2010; Montag et
al., 2010).
:
() () -
, ()
, ,
3 (-
) 5 ()
IVF
.
ESHRE (European Society of Human Reproduction and
Embryology)
(randomized trial)
. ,
226 42 -
40 ,
, :
() ARRAY CGH 24sure Bluegnome -
-
()
, -
-
( ) 89% .
-
, 3
-
.
ARRAY CGH
MYLIFE 29

H array CGH
.
1
.
21
19
3*
-
.
21
4
.
13
18 6.
5*
-
.
20
6
-
.
-
.
18
6p
7*
15, 16 18
8
9
10
1
*
-
,
ARRAY CGH
. -
-
t (16;17)
(q24:p11) - (41 ). -
,
,
-
. -
3
9 -
. ARRAY CGH 24sure+
(Bluegnome) -
1.
(3 )
(5 )
.
,
(3 -
) / -
. (3, 5
7) ,
,
-
, -
5 .
1, -
-
- 3 ,
-
.
30 MYLIFE

&
-
ARRAY CGH -
, -
FISH. ,
,
FISH.
1
,
-
ESHRE,
-
(polar body 1 & 2)
-
,
(
), -
-
-
.
12-16 ,
,
(vitrification) .
IVF ,
.
IVF.
1. Caglar GS, Asimakopoulos B, Nikolettos N et al. 2005 Preimplantation genetic diagnosis for aneuploidy screening in repeated implantation failure.
Reproductive BioMedicine Online 10, 381–388. 2. Donoso P, Devroey P 2007 PGD for aneuploidy screening: an expensive hoax? Best Practice and
Research. Clinical Obstetrics and Gynaecology 21, 157–168. 3. Fishel S, Gordon A, Lynch C et al. 2010 Live birth after polar body array comparative
genomic hybridization prediction of embryo ploidy-the future of IVF ? J Fertil steril 93, 1006-1010. 4. Fragouli E, Alfarawati S Daphnis DD et al.
2011 Cytogenetic analysis of human blastocysts with the use of FISH, CGH and aCGH: scientific data and technical evaluation. Human Reproduction
26, 480-90. 5. Gianaroli L, Magli MC, Ferraretti AP et al. 2005 The beneficial effects of preimplantation genetic diagnosis for aneuploidy support
extensive clinical application. Reproductive BioMedicine Online 10, 633–640. 6. Gutierez-Mateo C, Colls P, Sanchez-Garcia J et al. 2011 Validation of
microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 95, 953-8. 7. Kuliev A, Verlinsky
Y 2008 Impact of preimplantation genetic diagnosis for chromosomal disorders on reproductive outcome. Reproductive BioMedicine Online 16,
9–10. 8. Montag M, Koster K van der Ven K et al. 2010 Combined translocation and aneuploidy screening after polar body biopsy and array CGH. J
Reproductionsmed. Endokrinol 7, 498-502. 9. Munne S, Sandalinas M, Escudero T et al. 2003 Improved implantation after preimplantation genetic
diagnosis of aneuploidy. Reproductive BioMedicine Online 7, 91–97. 10. Munne S, Gianaroli L, Tur-Kaspa I et al. 2007a Substandard application of
preimplantation genetic screening may interfere with its clinical success. Fertility and Sterility 88, 781–784. 11. Munne S, Cohen J, Simpson JL 2007b
In-vitro fertilization with preimplantation genetic screening. New England Journal of Medicine 357, 1769–1770. 12. Voullaire L, Slater H, Williamson R
et al. 2000 Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Human Genetic 106, 210–217.
13. Wells D, Delhanty JD 2000 Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and
single cell comparative genomic hybridization. Molecular Human Reproduction 6, 1055-1062.
32 MYLIFE

MYLIFE 33

A
«-
»
.
"LOKOMAT".
&
-
,
,
.
LOKOMAT ,
, -
, ,
,
.D,MSc
.-
,
, -
.
-
– LOKOMAT -
.
34 MYLIFE

&
1.
2.
3.
4.
LOKOMAT ,
,
,
.
,
, 0%
100%.
LOKOMAT, -
– LOKOMAT ,
LOKOMAT
. ,
, , -
LOKOMAT,
– , 5%
. , ,
-
80 ,
4 .
-
LOKOMAT
. «» LOKOMAT
, -
5% 100% 5%.
LOKOMAT,
. ,
( , ,
, -
–heel strike phase-) , -
, ,
,
.
- LOKOMAT
.
–
, -
LOKOMAT, -
. , LOKOMAT,
, -
– ,
,
,
, –
, -
, .
MYLIFE 35

&
5.
6.
1 / 3,2 /,
-
- LOKOMAT.
, ,
LOKOMAT,
,
-
.
, LOKOMAT
-
-
,
,
.
-
, ,
(
- - ) -
, , -
, ,
-
. , -
LOKOMAT,
-
, -
.
. ,
,
.
1. Patritti BL, Straudi S, Deming LC, Benedetti MG, Nimec DL, Bonato P. Robotic gait training in an adult with cerebral palsy: a case report. PM R
2(1):71-75. 2010 2. Brutsch S, Schuler T, Koenig A, Zimmerli L, Merillat-Koeneke S, Lünenburger L, Riener R, Jäncke L, Meyer-Heim A.
Influence of virtual reality soccer game on walking performance in robotic assisted gait training for children. Journal of NeuroEngeneering and
Rehabilitation 7(15). 2010 3. Borggraefe I, Kiwull L, Schaefer JS, Koerte I, Blaschek A, Meyer-Heim A, et al. Sustainability of motor performance
after robotic-assisted treadmill therapy in children: an open, nonrandomized baseline-treatment study. Eur J Phys Rehabil Med. 2010 Feb 18.
2010 4. Wieser M, Haefeli J, Butler L, Jancke L, Riener R, Koeneke S. Temporal and spatial patterns of cortical activation during assisted lower
limb movement. Exp Brain Res 203(1):181-191. 2010 5. NHousman SJ, Scott KM, Reinkensmeyer DJ. A Randomized Controlled Trial of Gravity-
Supported, Computer-Enhanced Arm Exercise for Individuals With Severe Hemiparesis. Neurorehabilitation and Neural Repair, February 23, 2009,
doi:10.1177/1545968308331148 2009
36 MYLIFE

- .
-
A
-
,
-
. E
-
-
-
.
-
,
.
: () -
, () -,
() ()
. , () -
,
-
-
-
.
-
-
.
-
38 MYLIFE

- .
.
() -
. -
, -
,
.
,
. -
, -
, -
-
.
Meniere
, ,
.
. ,
.
,
, -
. ,
, -
,
. ,
, -
.
.
-
,
.
-
.
-
.
Schwann .
-
. 8
. -
-
,
,
9, 10 11 .
, -
-
(-knife),
-.
-
, -
.
, , -
,
. -
-
.
. ,
,
. -
, -
,
MYLIFE 39

.
.
.
- .
-
()
(-, -
-), () -
,
() -
.
,
. -
,
.
.
-
. -
.
,
Wallenberg
,
. -
-
. ,
, -
,
Wallenberg,
. .-
.
, -
. -
,
-
, -
.
.
-
,
-
-
.
1. . . : . (ed) . , , 1989.2. Brandt T, Strupp
M. General vestibular testing. Clin Neurophysiol. 2005;116(2):406-26. 3. Bronstein AM, Lempert T. Dizziness, a practical approach to diagnosis
and management. Cambridge clinical guide (series). Cambridge University Press, 2007. 4. Bronstein AM. Evaluation of balance. In: Scott-Brown’s
Otorhinolaryngology Head and Neck Surgery Edward Arnold (publishers) Ltd. 7th ed. London 2008. pp 3706-3747.5. Korres SG, Balatsouras DG.
Diagnostic, pathophysiologic, and therapeutic aspects of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2004;131(4):438-44.
6. Korres SG, Balatsouras DG, Papouliakos S, Ferekidis E. Benign paroxysmal positional vertigo and its management. Med Sci Monit. 2007;13(6):275-
82. 7. Korres SG, Balatsouras DG, Ferekidis E. Electronystagmographic findings in benign paroxysmal positional vertigo. Ann Otol Rhinol Laryngol
2004;113:313-318. 8. Korres S, Balatsouras DG, Kaberos A, Economou C, Kandiloros D, Ferekidis E. Occurrence of semicircular canal involvement in
benign paroxysmal positional vertigo. Otol Neurotol 2002;23:926-932. 9. Korres S, Riga M, Balatsouras D, Sandris V. Benign paroxysmal positional
vertigo of the anterior semicircular canal: atypical clinical findings and possible underlying mechanisms. Int J Audiol 2008;47:276-282
40 MYLIFE

MYLIFE 41

&
-
. , -
19 34 .
,
-
gel -
.
-
.
'60 -
’ .
80 .
,
...
42 MYLIFE

-
-
, .
-
(
),
.
1
.
,
,
, -
-
.
( )
() .
-
.
.
’ -
.
4
, ( )
. -
1 -
.
,
.
1
.
.
2-3
.
.
-
-
. -
-
,
.
1. Biggs TM, Humphreys DH: Augmentation mammaplasty. In Smith JW, Aston SJ (eds): Grabb and Smith’s Plastic Surgery, 4th ed. Boston, Little, Brown, 1991, pp 1145-1156 2.
LaTrenta GS: Breast augmentation. In Rees TD , LaTrenta GS (ed): Aesthetic Plastic Surgery, 2nd ed. Philadelphia, W.B. Saunders, 1994, pp 1003-1009. 3. Spear SL, Dawson KL:
Augmentation mammaplasty. In Cohen M (ed): Mastery of Plastic and reconstructive Surgery. Boston, Little, Brown, 1994, pp 2099-2113. 4. Young, V.L., Nemecek, J.R., and
Nemecek, D.A. The efficacy of breast augmentation: Breast size increase, patient satisfaction, and psychological effects. Plast. Reconstr. Surg. 94:959. 1994.
MYLIFE 43

30%-40%
,
, -
& ,
!
K &
-
“ , ”.
-
.
. BSc (Hons), MSc, NYSCDN
-
General
-
:
-
.
44 MYLIFE

K &
H
.
.
,
,
2%.
,
, 10%.
• .
• & .
•
.
•
.
(
).
, , ,
.
.
• ,
.
,
.
• ,
, .
«»
.
• , , .
• , , .
•
.
(2-4 )
, (,
.) .
• -3 (, , , ,
, ).
.
• . : ,
, ,
(.. ) (.. )
• D3.
• &
.
• ,
.
•
.
General.
.
MYLIFE 45

N
,
(
)
.
-
() -
-
-
.
H
.
ACRIN MUNICH -
-
,
IMPACT
-
(-
test ) -
SIGGAR .-
.
-
90% -
.
, / General
10 mm
78%
6 mm. 10
mm
-
1 cm .
( 85%
). SIGGAR
-
.
H
-
. -
)
, ) /
, )
46 MYLIFE

, ) -
-
, )
-
.
-
-
, -
, -
-
. -
-
.
-
,
( -
).
-
.
-
.
-
(screening)
.
( 2008)
(screening test)
-
,
-
. -
,
-
5 .
, -
,
, ,
, -
.
.
( )
/
-
-
.
, -
-
-
-
.
General,
. 210 650 2510-11
08.00 - 20.00 08.00 - 15.00.
1. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207–17. 2. Regge D, Laudi C,
Galatola G, et al. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. The
Italian Multicenter polyp accuracy computed tomographic colonography (IMPACT) study. J Am Med Assoc 2009;301:2453–61. 3. Graser A, Stieber P, Nagel D, et al. Comparison of
CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. GUT 2009;58:241–8. 4. Halligan
S, Lilford RJ, Wardle J, et al. Design of a multicentre randomized trial to evaluate CT colonography versus colonoscopy or barium enema for diagnosis of colonic cancer in older
symptomatic patients: the SIGGAR study. Trials 2007;8:32. 5. AGA Clinical Practice and Economics Committee. Position of the American Gastroenterological Association (AGA) Institute
on computed tomographic colonography. Gastroenterology 2006;131:1627–8. 6. Levin B, Lieberman DA, McFarland B, et al. Screening and Surveillance for the Early Detection of
Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American
College of Radiology. CA Cancer J Clin 2008;58:130-60.
MYLIFE 47

()
,
-
,
,
,
-.
&
-
( -
), -
(
) -
(
).
,
(NAFLD). -
-
-
(1) .
-
.
.-, General
,
, -
(2) .
, -
C, Wilson, ..
-
.
NAFLD
21-78%
(3) .
48 MYLIFE

&
.
;
.
. -
(-
-NASH)
(4) .
-
(-) -
() (5) .
NAFLD
.
-
(NASH),
,
.
NAFLD -
-
. (
)
(6) .
NAFLD -
.
( gt).
( SGPT)
/ gt. -
(7) .
.
-
MYLIFE 49

( ).
, -
, -
.
, -
-
>33% -
(8) .
-
, -
-
.
,
.
( )
(-
-) ( ). (9,10) . -
-
,
-
.
Fibroscan
()
, -
.
Fibroscan (. ),
, -
-
(
),
.
NAFLD
.
-
.
, -
/ .
,
-
, -
(, .).
-
(11) .
(Ursofalc), -
(12) ,
(13) .
&
1. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16:421-7
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis:summary of an AASLD single topic conference. Hepatology 2003;37:1202-19
3. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-
9. 4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, L indoor KD, Feldstein A, Angulo P. The natural history of non-alcoholic fatty liver disease: a
population-based cohort study. Gastroenterology 2005;129:113-21 5. Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis. Med Clin
North Am 1996;80:1147-66 6. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical
entity. Gastroenterology 1994;107:1103-9 7. Fargion S, Mattioli M, Francanzani Al, Sampietro M, Tavazzi D, Fociani P, et al. Hyperferritinemia, iron
overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:248-55 8. Saadeh
S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ, The utility of radiological imaging in non-alcoholic
fatty liver disease. Gastroenterology 2002;123:745-50. 9. Ahmed HM. Invasive and non-invasive investigations for non-alcoholic steatohepatitis. The
benefit of histology. Scand J Gastroenterology 2005;40:1260. 10. Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, McCulloch
AJ. Nonalcoholic fatty liver disease:assessment variability in pathologic interpretation. Mod Pathol 1998;11:560-5 11. Gomez-Dominguez E, Gisbert
JP, Monthsreno-Monthsnteagudo JA, Garcia-Buey L, Monthsreno-Otero R. A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty
liver patients. Aliment Pharmacol Ther 2006;23(11):1643-7. 12. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp
JF, Burgart L, Colin P. Ursodeoxycholic acid for treatment of non-alcoholic steatohepatitis: results of a randomized trial. Hepatology 2004;39:770-8
13.Lavine JE. Vitamin E treatment of non-alcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8
50 MYLIFE

GENERAL
General
& -
-
,
-
-
-
«
»
().
20 39
23 - 10 :
• -
,
General
• , General
.
General 30 -
30 .
-
"Mammographic Type Test" (EUREF)
.
-
.
General
-
, 15 ,
General
50% & --
30%
. -
12 -
30 2011
.
-
.
PSA ( ) &
Free-PSA ( ),
, -
3 .
j88 ( j176).
30%
-
,
,
.
45
PSA (free & total).
,
( 43, ’ 40 ),
.
General -
, , -
. -
, -
.
General -
Greenlight Laser.
52 MYLIFE

General
-
General -
, - .
General
-
.
,
,
.
General,
-
.
-
-
.
9,5 -
-
-
2 . , -
,
, -
-
.
-
-
-
. -
-
. -
-
.
3
General
27 28 2011
General, 3
-
« -
» .
-
.
Mr.Tony Bull,
& -
. -
-
-
. ,
-
.
,
.
MYLIFE 53

-
23 -
.
-
-
.
.
‘
, . «
,
-
.
,
… ».
.
. EUROTAXI,
, -
1 .
500 01/06/2011
- 30/06/2011
(check-up) .
-
.
,
23 -
.
,
, -
.
. ,
. /
, .
& ()
-
-
,
,
.
-
,
, ,
, .
. ,
.
, , .
, « -
»
-
,
.
54 MYLIFE

13/5/11, -
.
, ,
/ .
-
. / -
.
. , .
.
«…
. ‘ ,
. -
, .
.
-
.
, .
,
.
.
,
.
.
.
. -
,
-
.
.
,
.
.»
, -
-
Mountain Camp .
-
.
, -
-
-
.
MYLIFE 55

A
-
-
(). -
,
,
,
. , -
-
,
, triplex .
-
. -
.
-
, , ..., .... ()
....
( , Generali .).
-
-
.
-
-
,
-
, «»
.
17
, -
, , -
.
, .
. . -
, .
. .
.
.
EUROTAXI
• • 250 •
• ,
• • 24 /
• ( )
... 14 8 40
(X: g0,37 / , g0,64 / )
1. 2410 661414
.
2. ,
.
SMS o 54999 ( ) (X: g1,23 / SMS)
e-mail: rantevou@eurotaxi-larissas.gr
: 2310 566 500
www.eurotaxi-larissas.gr
56 MYLIFE

-
• ()
•
triplex
• (follow-up)
•
• (IVF)
• &
•
•
( )
-
9
&
ILTON A
9 -
, ,
16
(Hands on) 17
18 2011 ILTON A.
, .
«-
». -
,
-
.
-
,
-
.
-
-
-
.
.
MYLIFE 57

-
« - » -
-
.
,
8 15 -
, -
-
.
, -
-
-
,
, , -
.
, -
, « - -
» -
.
&
,
«»
,
.
,
-
.
, -
-
,
’
20% .
(-
, , , . )
-
,
75
-
.
-
12/10/11 -
K A-
A -
,
.
- -
(HYDROPHYSIO,
, LOKOMAT, ERIGO)
.
«» -
,
, -
..
-
& General
.
58 MYLIFE

...
,
My Club Card VISA
• VISA
.
• chip
.
•
,
.
•
.
My Club Card,
-
,
,
, .
, GENERAL,
, &
.
j4,000
My club card VISA
Check up -
-
.
:
: : 210 6184111
GENERAL: : 210 6502660
E-mail: myclubcard@iaso.gr
My Club Card
.
www.myclubcard.gr

My Club Card VISA
!
My Club Card VISA
:
• 1
: , Lux, , Superior
: 12 , , Superior & : 6 .
• 15% 2
.
• 6
() Cryobanks.
• 6
.
• 6 (IVF).
• 6
.
• 6 laser, ,
& .
• 6 .
My Club Card VISA
:
• € 20
.
• 20% 1 .
• 20% 2
.
• 6 .
•
, 1 , 1 & 1 .
• € 150.
• .
My Club Card VISA
:
•
.
• 15% &
• 15%
L, ERIGO , HYDROPHYSIO.
• 10% LASER
• 6 1 .
60 MYLIFE

My Club Card
My Club Card VISA !
My Club Card VISA
General :
• 6 1 .
• € 15
: , , .
• 15% 2
.
• 6
FNA.
• 6 7 3
4 .
•
.
My Club Card VISA :
• 6 1 .
• 6 () Cryobanks.
1
Έξαιρούνται οι αμοιβές των ιατρών, φάρμακα και υλικά.
2
Από τις εκπτώσεις εξαιρούνται οι εξετάσεις που τιμολογούνται με ειδικές τιμές ή με τιμές παραπλήσιες του ΦΕΚ.
&
j75 j240 .
check-up My Club Card VISA
,
My Club Card VISA. S4,000
,
.
.
210-618 4000
check up.
MYLIFE 61

!
– 2- Calma.
-
, -
: Medela
2- -
. Calma
,
.
www.klinicum.gr
Frezyderm
Baby Line
H Frezyderm -
Baby Line, 2 . -
,
Barcodes -
Baby Line . 5 barcodes
fleece , 8
barcodes - ! -
30 2011 .
Frezyderm, 75, 104 37, , .: 210 5246900, Fax: 210 5244433
www.frezyderm.gr
K & Peramax.
max!
-
Peramax.
Peg-Perego, Playgro, Britax &
Romer, Peramax.
, , -
service . -
, -
. , -
online www.peramax.gr. Peramax
Peg-Perego service .
www.peramax.gr
62 MYLIFE
!
www.babyzone.gr
, , , -
. , !
, !
! -
! inbox newsletter!
babyzone.gr. !
facebook: www.facebook.com/www.babyzone.gr

Bordeux
KIDSCOM
, , ,
. Bordeux
kidscom , -
Kidscom
,
…
, , ,
,
.
, -
.
Concord Travel Set
KIDSCOM
Kidscom
3 , ,
! , -
’ , . NEO Concord
. , .
-
! To Concord
. , -
, . -
Concord -
! (0
+),
.
, .
. 128 .2108067150
. 62 .2109830570
. 3 . .2106014624
e-shop: www.kidscom.gr
O
I-FEEL
I-Feel Chicco
, .
• •
,
« » •
•
•
• •
• -
• ,
,
• MP3 • 9 • : 3,8
Pure Bio Chicco
… !
. ,
,
.
, ,
.
pure.bio Chicco Ecocert.
www.chicco.gr
MYLIFE 63

,
-
-
.
1. 10
/ / «
» 1
* 08:00 13:00,
210 618 4178 & 210 618 4189 ( . . 4178 & 4189).
2. :
• (
).
• 2 ().
,
.
, -
(4 )
, j15,00 .
-
,
.
-
:
. 9 & . ,
15124 ,
.: 213 2038000, : 213 2038500
url: www.maroussi.gr
e-mail: info@maroussi.gr
*
, -
1
.
-
, -
.
. 2413 507230
http://kileler.gov.gr
email: dnikaias@gmail.com
64 MYLIFE

Μπορούμε να είμαστε πρωτοπόροι
και στις υπηρεσίες Υγείας του μέλλοντος.
Τομέας Υγείας
Οι άνθρωποι στηρίζονται σε εμάς, σήμερα και αύριο,
για να βρουν καινοτόμες λύσεις που θα τους βοηθήσουν
να διατηρηθούν υγιείς και να απολαμβάνουν καλύτερες
υπηρεσίες Υγείας.
Η Siemens διαθέτει ενοποιημένες τεχνολογίες απεικόνισης
και πληροφοριακών συστημάτων στον Τομέα Υγείας, που
μπορούν να βοηθήσουν στην καλύτερη πρόληψη,
διάγνωση, θεραπεία και ιατρική φροντίδα με νέες
μεθόδους.
Μαζί μπορούμε να ανταποκριθούμε στην υπόσχεση
για εξατομικευμένη ιατρική φροντίδα για τις επόμενες
γενιές.
siemens.com/healthcare